Clinical trials
Phase 2 Anemia trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 2 |
| 2006 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2014 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 4 |
| Bayer | 3 |
| Novartis Pharmaceuticals | 2 |
| Takeda | 2 |
| A. Manzoni Hospital | 1 |
| Agios Pharmaceuticals, Inc. | 1 |
| Associazione Qol-one | 1 |
| Bristol-Myers Squibb | 1 |
| CSL Behring | 1 |
| Celgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 21 |
| Renal Insufficiency, Chronic | 4 |
| Primary Myelofibrosis | 3 |
| Thrombocytopenia | 3 |
| Anemia, Sickle Cell | 2 |
| Genetic Diseases, Inborn | 2 |
| Hematologic Diseases | 2 |
| Hemolysis | 2 |
| Iron Overload | 2 |
| Myelodysplastic Syndromes | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.